Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Option Care Health (OPCH)

Tipranks - Fri Feb 27, 7:16AM CST

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fortrea Holdings Inc. (FTREResearch Report) and Option Care Health (OPCHResearch Report).

Claim 50% Off TipRanks Premium

Fortrea Holdings Inc. (FTRE)

William Blair analyst Max Smock reiterated a Hold rating on Fortrea Holdings Inc. today. The company’s shares closed last Wednesday at $10.34, close to its 52-week low of $8.00.

According to TipRanks.com, Smock has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -19.8% and a 24.1% success rate. Smock covers the Healthcare sector, focusing on stocks such as Lifecore Biomedical, Charles River Labs, and Simulations Plus. ;'>

Fortrea Holdings Inc. has an analyst consensus of Moderate Buy, with a price target consensus of $16.17.

See today’s best-performing stocks on TipRanks >>

Option Care Health (OPCH)

In a report released today, Michael Petusky from Barrington maintained a Buy rating on Option Care Health, with a price target of $42.00. The company’s shares closed last Wednesday at $33.60, close to its 52-week high of $35.53.

According to TipRanks.com, Petusky is a 2-star analyst with an average return of 0.4% and a 44.6% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, US Physical Therapy, and Anika Therapeutics. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Option Care Health with a $39.50 average price target, representing a 15.6% upside. In a report released yesterday, Morgan Stanley also maintained a Buy rating on the stock with a $38.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.